MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

A (medicines beginning with A) B (medicines beginning with B) C (medicines beginning with C) D (medicines beginning with D) E (medicines beginning with E) F (medicines beginning with F) G (medicines beginning with G) H (medicines beginning with H) I (medicines beginning with I) K (medicines beginning with K) L (medicines beginning with L) M (medicines beginning with M) N (medicines beginning with N) O (medicines beginning with O) P (medicines beginning with P) Q (medicines beginning with Q) R (medicines beginning with R) S (medicines beginning with S) T (medicines beginning with T) U (medicines beginning with U) V (medicines beginning with V) W (medicines beginning with W) X (medicines beginning with X) Y (medicines beginning with Y) Z (medicines beginning with Z)

Medicines beginning with O

Olmesartan + Amlodipine

Olmesartan medoxomil 20mg / Amlodipine 5mg tablets

Use with caution

Stability notes for Olmesartan medoxomil 20mg / Amlodipine 5mg tablets

Moisture sensitive medicine. Store in airtight (sealed) MCA.  Light sensitive medicine. Store in light resistant container. No stability data in MCAs available.

Provenance

This recommendation is based on the products Sevikar 20mg/5mg tablets (Daiichi Sankyo UK Limited) and olmesartan medoxomil/amlodipine 20mg/5mg tablets (Accord Healthcare Limited).

Supplier

Sevikar 20mg/5mg tablets (CST Pharma Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.